NCT00625456: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors |
|
|
| Completed | 1 | 23 | US, Canada | Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594), JX-594 | Jennerex Biotherapeutics | Melanoma, Lung Cancer, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck | 04/10 | 06/14 | | |
NCT01169584: Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients |
|
|
| Completed | 1 | 6 | US | Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594), Pexa-Vec | Jennerex Biotherapeutics, Solving Kids' Cancer | Neuroblastoma, Rhabdomyosarcoma, Lymphoma, Wilm's Tumor, Ewing's Sarcoma | 03/12 | 11/14 | | |
